Application Notes

Cellastim S – Reconstitution Application Note

rHSA Reconstitution Video Protocol

Exbumin – Stabilizing Virus with Albumin to Improve Yield Application Note

OptiVERO – Expansion of VERO Cells Without Serum in Chemically Defined Cell Culture Media

OptiVERO – Virus Production Using VERO Cells in Flasks without Serum in Chemically Defined Cell Culture Media Application Note

OptiVERO – Virus Production Using VERO Cells with Microcarriers Without Serum in Chemically Defined Cell Culture Media

T Cell Cryopreservation Using Exbumin®, Recombinant Human Serum Albumin, and Reduced DMSO

Blog

Evolving Challenges in Closed-System Biomanufacturing

Optibumin vs Traditional Albumin: Comparing Performance in Cell Wash Applications

Recombinant Virus Platforms are Out in Front in the Race to Develop Vaccines Against SARS-CoV-2 and COVID-19 Disease

Scaling Innovation: How DiscGenics and InVitria are Leading the Future of Cell Therapy

Solving the Vaccine Supply Challenge

Journal Articles (DOI Links)

Formulation and Production of a Blood-free and Chemically Defined Virus Production Media for VERO Cells

Posters

Cellastim S – Optimizing Antibody Production in Animal-Free Media with the Supplementation of Recombinant Human Albumin

Product Brochures

ITSE AF – Brochure

Optiferrin – Product Brochure

Product Specifications

ITS – Specifications

SDS

ITSE AF – Safety Data Sheet

Use Guidelines

OptiFRZ Guidelines for Use

Exbumin – Guidelines for Use

ITS – Guidelines for Use

ITSE AF – Guidelines for Use

ITSE+A – Guidelines for Use

Optiferrin – Guidelines for Use

Webinar

Accelerating Vaccine Development Through Use of Blood-Free Components

White Papers

Emergence of Blood-Free Recombinant Human Albumin

VERO Expansion in the iCellis® Bioreactor with Chemically Defined and Blood Free Virus Production Media